Catalyst Pharmaceuticals, Inc. (CPRX) — 8-K Filings

8-K Filings (26)

• Catalyst Pharmaceuticals Files 8-K — Oct 1, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on October 1, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is based
• Catalyst Pharmaceuticals Files 8-K — Aug 25, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on August 25, 2025, reporting on other events and financial statements. The filing details the company's corporate s
• Catalyst Pharmaceuticals Files 8-K — Aug 7, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on August 7, 2025, reporting an event that occurred on August 6, 2025. The filing is categorized under 'Other Events
• Catalyst Pharmaceuticals Files 8-K — Aug 6, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on August 6, 2025, reporting other events and financial statements. The filing details the company's corporate infor
• Catalyst Pharmaceuticals Files 8-K: Director Changes & Officer Compensation — Aug 4, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on August 4, 2025, reporting on the departure of a director, election of a new director, and changes in compensatory
• Catalyst Pharmaceuticals Files 8-K — Jun 2, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on June 2, 2025, reporting an event that occurred on June 1, 2025. The filing indicates 'Other Events' and 'Financia
• Catalyst Pharmaceuticals Files 8-K on Director, Officer, and Compensation Changes — May 23, 2025 Risk: medium
  Catalyst Pharmaceuticals, Inc. announced on May 20, 2025, changes in its board of directors and executive compensation arrangements. The company also reported o
• Catalyst Pharmaceuticals Files 8-K — May 7, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific detai
• Catalyst Pharmaceuticals Files 8-K — Apr 9, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on April 9, 2025, reporting an event that occurred on April 8, 2025. The filing is categorized under 'Other Events'
• Catalyst Pharmaceuticals Files 8-K — Feb 26, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on February 26, 2025, reporting other events and financial statements. The filing details the company's corporate in
• Catalyst Pharmaceuticals Appoints New Director — Jan 24, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. announced on January 17, 2025, a change in its board of directors. Specifically, Dr. Richard J. Peterson has been appointed as a
• Catalyst Pharmaceuticals Files 8-K — Jan 21, 2025 Risk: low
  On January 21, 2025, Catalyst Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine cor
• Catalyst Pharmaceuticals Files 8-K — Jan 13, 2025 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not
• Catalyst Pharmaceuticals Files 8-K — Jan 8, 2025 Risk: low
  On January 8, 2025, Catalyst Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific materi
• Catalyst Pharmaceuticals Files 8-K — Nov 6, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on November 6, 2024, reporting other events and financial statements. The filing details the company's incorporation
• Catalyst Pharma to Acquire New Product — Sep 26, 2024 Risk: medium
  Catalyst Pharmaceuticals, Inc. announced on September 24, 2024, that it has entered into a definitive agreement to acquire a pharmaceutical product from a third
• Catalyst Pharmaceuticals Files 8-K — Aug 7, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on August 7, 2024, reporting other events and financial statements/exhibits. The company, incorporated in Delaware,
• Catalyst Pharma Acquires Firdapse Rights — Jul 26, 2024 Risk: medium
  Catalyst Pharmaceuticals, Inc. announced on July 24, 2024, that it has entered into a definitive agreement to acquire the U.S. rights to Firdapse from Adare Pha
• Catalyst Pharmaceuticals Files 8-K — May 30, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on May 30, 2024, to report other events and financial statements. The filing does not contain specific details on ne
• Catalyst Pharma Unveils New Equity Incentive Plan — May 21, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. announced on May 21, 2024, that its Board of Directors has approved a new equity incentive plan, the 2024 Equity Incentive Plan.
• Catalyst Pharmaceuticals Files 8-K — Mar 13, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on March 13, 2024, to report other events and financial statements. The filing does not contain specific details on
• Catalyst Pharma Files Routine 8-K, No New Material Events — Feb 29, 2024 Risk: low
  Catalyst Pharmaceuticals, Inc. filed an 8-K on February 28, 2024, reporting on 'Other Events' and 'Financial Statements and Exhibits'. The filing indicates no s
• Catalyst Pharma Files 8-K on Other Events and Exhibits — Feb 21, 2024 Risk: low
  CATALYST PHARMACEUTICALS, INC. filed an 8-K on February 21, 2024, reporting 'Other Events' and 'Financial Statements and Exhibits'. The filing indicates a curre
• Catalyst Pharma Files 8-K, Confirms NASDAQ Listing — Jan 9, 2024
  Catalyst Pharmaceuticals, Inc. filed an 8-K on January 9, 2024, to report an "Other Event" and "Financial Statements and Exhibits." This filing primarily serves
• Catalyst Pharma Confirms NASDAQ Listing in 8-K Filing — Jan 8, 2024
  Catalyst Pharmaceuticals, Inc. filed an 8-K on January 8, 2024, to disclose that its common stock, with a par value of $0.001 per share, is registered on the NA
• Catalyst Pharma Files 8-K on Material Agreement; Details Pending — Jan 5, 2024
  On January 4, 2024, Catalyst Pharmaceuticals, Inc. filed an 8-K to report an "Entry into a Material Definitive Agreement" and "Regulation FD Disclosure." While

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX